TABLE 2.
Razupenem T>MIC targets required for a bacteriostatic effect and for 1-, 2-, and 3-log-unit reductions in S. aureus viable counts at 24 h and 48 h
| Time (h) | Effect |
T>MIC (%) for strain (MIC, mg/liter): |
|||||||
|---|---|---|---|---|---|---|---|---|---|
| MSSA 5956 (0.015) | MRSA 33922 (0.09) | MRSA 36895 (0.38) | VISA 19898 (1.5) | MRSA 27706 (1.5) | MRSA 33820 (3.0) | MRSA, avg ± SD | MRSA, pooled analysis | ||
| 24 | Static | 23.6 | 6.7 | 4.5 | 3.9 | 6.4 | 3.6 | 5.0 ± 1.4 | 4.0 |
| 1.0-log-unit reduction | 31.5 | 13.4 | 18.4 | 7.3 | 17.7 | 5.7 | 12.5 ± 5.8 | 9.0 | |
| 2.0-log-unit reduction | 40.9 | 23.5 | 31.9 | 11.8 | 33.3 | 9.2 | 21.9 ± 11.1 | 16.1 | |
| 3.0-log-unit reduction | 53.0 | 40.9 | 18.9 | 59.1 | 36.6 ± 20.1 | 31.4 | |||
| r2 | 0.685 | 0.881 | 0.910 | 0.958 | 0.807 | 0.882 | 0.800 | ||
| 48 | Static | 31.5 | 12.8 | 9.7 | 10.3 | 6.4 | 6.0 | 9.0 ± 2.8 | 7.8 |
| 1.0-log-unit reduction | 35.9 | 23.5 | 16.8 | 13.7 | 11.8 | 7.6 | 14.7 ± 5.9 | 14.1 | |
| 2.0-log-unit reduction | 39.6 | 36.2 | 25.2 | 17.2 | 19.5 | 9.2 | 21.5 ± 10.4 | 22.1 | |
| 3.0-log-unit reduction | 45.0 | 55.0 | 38.0 | 22.3 | 35.5 | 12.2 | 32.6 ± 16.3 | 34.9 | |
| r2 | 0.972 | 0.984 | 0.963 | 0.966 | 0.8639 | 0.895 | 0.881 | ||